Nuvectis Pharma, Inc. (NVCT)
NCM · Common · CUSIP 67080T108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NVCT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
67080T108
Market Cap
Small Cap
IPO
2/4/2022 · $5.00/share
Business: Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology.

Company Contact

CEO
Ron Bentsur
CFO
Uri Ben-Or
Headquarters
1 Bridge Plaza, Suite 275, Fort Lee, NJ, 07024
Phone
201-614-3150
Investor Relations
Ron Bentsur · 201-614-3151 · rbentsur@nuvectis.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »